About RxSight
RxSight is a company based in Aliso Viejo (United States) founded in 1997. RxSight has raised $198.76 million across 12 funding rounds from investors including RA Capital, Oxford Finance and Flying L Partners. The company has 498 employees as of December 31, 2024. RxSight offers products and services including Light Adjustable Lens, Light Adjustable Lens+, and Light Delivery Device. RxSight operates in a competitive market with competitors including Atia Vision, STAAR Surgical, Nayam Innovations, WaveTec Vision and Wuxi Vision Pro, among others.
- Headquarter Aliso Viejo, United States
- Employees 498 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Rxsight, Inc.
-
Annual Revenue
$139.93 M (USD)57.09as on Dec 31, 2024
-
Net Profit
-$27.45 M (USD)43.52as on Dec 31, 2024
-
EBITDA
-$33.23 M (USD)27.5as on Dec 31, 2024
-
Total Equity Funding
$198.76 M (USD)
in 12 rounds
-
Latest Funding Round
$60 M (USD), Debt – Conventional
Dec 02, 2020
-
Investors
RA Capital
& 5 more
-
Employee Count
498
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of RxSight
RxSight is a publicly listed company on the NASDAQ with ticker symbol RXST in USA, operating in the Electronic technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of RxSight
RxSight offers a comprehensive portfolio of products and services, including Light Adjustable Lens, Light Adjustable Lens+, and Light Delivery Device.
Customizable lens for post-cataract vision adjustment and astigmatism correction.
Enhanced version for vision correction after eye surgery.
Device for adjusting lenses post-surgery to improve visual acuity.
People of RxSight
Unlock access to complete
Unlock access to complete
Leadership Team
19 people
Sales and Marketing
15 people
Clinical Team
14 people
Software Development Team
12 people
Account Team
12 people
Operations Team
8 people
Finance and Accounting
6 people
Senior Team
6 people
Unlock access to complete
Funding Insights of RxSight
RxSight has successfully raised a total of $198.76M across 12 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $60 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in RxSight
RxSight has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include RA Capital, Oxford Finance and Flying L Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt firm focused on the life sciences sector
|
Locked | Locked | Locked | |
|
Flying L Partners is focused on ophthalmic sector investments.
|
Locked | Locked | Locked | |
|
Private equity firm focused on life science sector
|
Locked | Locked | Locked |
Investor details for RxSight
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RxSight
Investment portfolio details for RxSight
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RxSight
Detailed financials for RxSight
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rxsight Comparisons
Peer comparison for RxSight
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RxSight
RxSight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Atia Vision, STAAR Surgical, Nayam Innovations, WaveTec Vision and Wuxi Vision Pro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A presbyopia-correcting intraocular lens is developed for cataract patients.
|
|
| Locked | Locked | Locked |
Manufacturer of implantable lenses for the eye with companion delivery systems
|
|
| Locked | Locked | Locked |
Artificial intraocular lenses for cataract treatment are developed.
|
|
| Locked | Locked | Locked |
Intraoperative guidance for IOL alignment in cataract surgery is offered.
|
|
| Locked | Locked | Locked |
Manufacturer of intraocular lenses and related products
|
Detailed competitors of RxSight
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rxsight
Complete news archive for RxSight
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RxSight
RxSight was founded in 1997 and raised its 1st funding round 5 years after it was founded.
RxSight is headquartered in Aliso Viejo, United States. It is registered at Aliso Viejo, California, United States.
RxSight is a funded company, having raised a total of $198.76M across 12 funding rounds to date.
As of Dec 31, 2024, the latest employee count at RxSight is 498.
Annual revenue of RxSight is $139.93M as on Dec 31, 2024.
Founded in 1997 and headquartered in Aliso Viejo, United States, RxSight operates in the medical device sector focused on ophthalmology. An adjustable intraocular lens platform has been engineered, incorporating biocompatible materials responsive to targeted ultraviolet wavelengths. Photopolymerization is induced upon exposure, enabling precise alterations to lens curvature for customized vision outcomes. Operations center on advancing this technology for cataract surgery applications, with ongoing development conducted from the U.S. base.
RxSight's top competitors include Nayam Innovations, Atia Vision and STAAR Surgical.
RxSight offers Light Adjustable Lens, Light Adjustable Lens+, and Light Delivery Device.
Yes, RxSight is publicly traded on NASDAQ under the ticker symbol RXST.
RxSight has 6 investors. Key investors include RA Capital, Oxford Finance, Flying L Partners, HIG BioHealth Partners, and Longitude Capital.
The ticker symbol of RxSight is RXST on NASDAQ.